TABLE 2.
Frozen section | Paraffin section | |
---|---|---|
Number of patients (sections) | 7 (7) | 57 (59) |
Age mean ± SD (years) | 75 ± 6 years | 73 ± 10 years |
Age range | 67–84 | 46–87 |
Sex | ||
male | 5 (71%) | 45 (79%) |
female | 2 (29%) | 12 (21%) |
Clinical stage | ||
0a | 2 (29%) | 30 (51%) |
0is | 0 | 1 (2%) |
I | 3 (42%) | 18 (31%) |
II | 0 | 5 (8%) |
III | 0 | 2 (3%) |
IV | 2 (29%) | 3 (5%) |
Tumor classification | ||
a | 2 (29%) | 30 (51%) |
Cis | 0 | 1 (2%) |
1 | 3 (42%) | 18 (31%) |
2 | 0 | 5 (8%) |
3 | 1 (14%) | 4 (6%) |
4 | 1 (14%) | 1 (2%) |
Node classification | ||
0 | 5 (71%) | 56 (95%) |
1 | 2 (29%) | 2 (3%) |
2 | 0 | 0 |
3 | 0 | 1 (2%) |
metastasis classfication | ||
0 | 6 (86%) | 56 (95%) |
1 | 1 (14%) | 3 (5%) |
Grading | ||
1 | 2 (29%) | 13 (22%) |
2 | 3 (42%) | 32 (54%) |
3 | 2 (29%) | 14 (24%) |
Histology | ||
Urothelial carcinoma | 6 (86%) | 58 (98%) |
small cell carcinoma | 1 (14%) | 1 (2%) |
Invasiveness | ||
non-invasive | 2 (29%) | 31 (53%) |
invasive | 5 (71%) | 28 (47%) |
Variant/differentiation | ||
glandular differentiation | 0 | 1 (4%) |
squamous differentiation | 0 | 3 (11%) |
sarcomatoid variant | 1 (14%) | 3 (11%) |
micropapillary variant | 0 | 1 (4%) |
plasmacytoid variant | 1 (14%) | 0 |